Vitamin D and COVID-19: Narrative Review after 3 Years of Pandemic
暂无分享,去创建一个
M. Cutolo | A. Sulli | C. Pizzorni | V. Smith | S. Paolino | E. Gotelli | S. Soldano | E. Hysa | R. Campitiello
[1] W. Zgliczyński,et al. Effect of Vitamin D Concentration on Course of COVID-19 , 2022, Medical science monitor : international medical journal of experimental and clinical research.
[2] F. Lund-Johansen,et al. Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial , 2022, BMJ.
[3] David A. Jolliffe,et al. Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT) , 2022, BMJ.
[4] David A. Jolliffe,et al. Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial , 2022, Nutrients.
[5] A. Zhang,et al. Serial negative response after standard and third (Booster) dose of COVID-19 inactivated vaccine is associated with low vitamin D levels in patients with solid cancers , 2022, Frontiers in Medicine.
[6] A. Rousseau,et al. Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial , 2022, Nutrients.
[7] M. López-Alarcón,et al. Efficacy and safety of vitamin D supplementation in hospitalized COVID-19 pediatric patients: A randomized controlled trial , 2022, Frontiers in Pediatrics.
[8] Yanzhang Gao,et al. Vitamin D levels and clinical outcomes of SARS-CoV-2 Omicron subvariant BA.2 in children: A longitudinal cohort study , 2022, Frontiers in Nutrition.
[9] F. Chiaradonna,et al. Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis , 2022, PloS one.
[10] M. Coiras,et al. Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D3 in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial , 2022, Frontiers in Pharmacology.
[11] H. Eini-Zinab,et al. Vitamin D deficiency is Associated with Increased Risk of Delirium and Mortality among Critically Ill, Elderly Covid-19 Patients , 2022, Complementary Therapies in Medicine.
[12] W. Grant,et al. Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study , 2022, Nutrients.
[13] T. Streichert,et al. The ratio of serum LL-37 levels to blood leucocyte count correlates with COVID-19 severity , 2022, Scientific Reports.
[14] N. Binkley,et al. Serum 25-hydroxyvitamin D Concentration Significantly Decreases in Patients with COVID-19 Pneumonia during the First 48 Hours after Hospital Admission , 2022, Nutrients.
[15] M. Cominetti,et al. Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19 , 2022, Clinical Nutrition ESPEN.
[16] F. Inserra,et al. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: Multicentre randomized controlled clinical trial , 2022, PloS one.
[17] A. Barron,et al. Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis , 2022, Frontiers in Immunology.
[18] Erfan Kazemi,et al. Comparison of the cardiovascular system, clinical condition, and laboratory results in COVID-19 patients with and without vitamin D insufficiency , 2022, BMC Infectious Diseases.
[19] M. Bennett,et al. 25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients , 2022, PloS one.
[20] C. Annweiler,et al. High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial , 2022, PLoS medicine.
[21] J. Lieberman,et al. FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation , 2022, Nature.
[22] M. López-Alarcón,et al. Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in Frontline Healthcare Workers. A Randomized Clinical Trial , 2022, Archives of Medical Research.
[23] N. Tsugawa,et al. Association between 25-hydroxyvitamin D levels and COVID-19 severity , 2022, Clinical Nutrition ESPEN.
[24] J. Lieberman,et al. Inflammasome activation in infected macrophages drives COVID-19 pathology , 2021, Nature.
[25] Xia Li,et al. Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells , 2022, Cellular & Molecular Immunology.
[26] H. L. Banh,et al. Effects of Vitamin D Serum Level on Morbidity and Mortality in Patients with COVID-19: A Systematic Review and Meta-Analysis. , 2022, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[27] P. Moss. The T cell immune response against SARS-CoV-2 , 2022, Nature Immunology.
[28] Chao Sui,et al. SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy , 2022, The Journal of Immunology.
[29] Ali I. Al-Gareeb,et al. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality , 2022, International Immunopharmacology.
[30] D. Thickett,et al. Vitamin D status: a U-shaped relationship for SARS-CoV-2 seropositivity in UK healthcare workers , 2021, BMJ Open Respiratory Research.
[31] Amy Moore,et al. The Relationship of Serum 25-Hydroxyvitamin D at Admission and Severity of Illness in COVID-19 Patients. , 2022, Medical journal.
[32] J. Denkovskij,et al. The Expression of Inflammasomes NLRP1 and NLRP3, Toll-Like Receptors, and Vitamin D Receptor in Synovial Fibroblasts From Patients With Different Types of Knee Arthritis , 2022, Frontiers in Immunology.
[33] S. Gordon,et al. SARS-CoV-2 Variants, Vaccines, and Host Immunity , 2022, Frontiers in Immunology.
[34] I. Chiodini,et al. Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes , 2021, Frontiers in Public Health.
[35] P. Katulanda,et al. Prognostic and therapeutic role of vitamin D in COVID-19: systematic review and meta-analysis , 2021, The Journal of clinical endocrinology and metabolism.
[36] C. Annweiler,et al. Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1 , 2021, Nutrients.
[37] A. Kittaka,et al. The Synthesis and Biological Evaluation of D-Ring-Modified Vitamin D Analogues , 2021, Biomolecules.
[38] M. Ishii,et al. The Effects of Vitamin D on Immune System and Inflammatory Diseases , 2021, Biomolecules.
[39] Daniel S. Chertow,et al. Autocrine Vitamin D-signaling switches off pro-inflammatory programs of Th1 cells , 2021, Nature immunology.
[40] A. Aversa,et al. Corrigendum to: Influence of 25‑hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis [EClinicalMedicine 37 (2021) 100,967] , 2021, EClinicalMedicine.
[41] Khalid J. Alzahrani,et al. Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis , 2021, Frontiers in Immunology.
[42] S. Hernández-Jiménez,et al. Very Low Vitamin D Levels are a Strong Independent Predictor of Mortality in Hospitalized Patients with Severe COVID-19 , 2021, Archives of Medical Research.
[43] M. Sahraian,et al. Treatment With 25-Hydroxyvitamin D3 (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial , 2021, Endocrine Practice.
[44] A. Carmo,et al. Crosstalk between estrogen, dendritic cells, and SARS‐CoV‐2 infection , 2021, Reviews in medical virology.
[45] Z. Rao,et al. Structural biology of SARS-CoV-2 and implications for therapeutic development , 2021, Nature Reviews Microbiology.
[46] Ping Fan,et al. Role of vitamin D/VDR nuclear translocation in down-regulation of NF-κB/NLRP3/caspase-1 axis in lupus nephritis. , 2021, International immunopharmacology.
[47] Michael A. Via,et al. A randomized pilot study using calcitriol in hospitalized COVID-19 patients , 2021, Bone.
[48] C. Zheng,et al. Putative Role of Vitamin D for COVID-19 Vaccination , 2021, International journal of molecular sciences.
[49] R. Scheuermann,et al. Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals , 2021, Cell Reports Medicine.
[50] S. Kalra,et al. The Impact of Vitamin D Deficiency on the Severity of Symptoms and Mortality Rate among Adult Patients with Covid-19: A Systematic Review and Meta-Analysis , 2021, Indian journal of endocrinology and metabolism.
[51] Kang Chen,et al. Vitamin D promotes autophagy in AML cells by inhibiting miR-17-5p-induced Beclin-1 overexpression , 2021, Molecular and Cellular Biochemistry.
[52] N. Al-Daghri,et al. Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial , 2021, Nutrients.
[53] Zhen Wang,et al. Association of vitamin D deficiency with COVID‐19 infection severity: Systematic review and meta‐analysis , 2021, Clinical endocrinology.
[54] C. Conrad,et al. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals , 2021, Nature Communications.
[55] R. Rappuoli,et al. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules , 2021, Nature Immunology.
[56] M. Antonelli,et al. Low Serum Levels of 25-Hydroxyvitamin D Accompany Severe COVID-19 Because it is a Negative Acute Phase Reactant , 2021, The American Journal of the Medical Sciences.
[57] J. Muñóz-Valle,et al. Vitamin D Levels in COVID-19 Outpatients from Western Mexico: Clinical Correlation and Effect of Its Supplementation , 2021, Journal of clinical medicine.
[58] Y. Tizabi,et al. Vitamin D and COVID‐19: Role of ACE2, age, gender, and ethnicity , 2021, Journal of medical virology.
[59] T. Bal,et al. Beclin-1, an autophagy-related protein, is associated with the disease severity of COVID-19 , 2021, Life Sciences.
[60] Dongqing Wei,et al. Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone , 2021, ACS infectious diseases.
[61] David A. Jolliffe,et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. , 2021, The lancet. Diabetes & endocrinology.
[62] R. Pranata,et al. Low Serum 25-hydroxyvitamin D (Vitamin D) Level Is Associated With Susceptibility to COVID-19, Severity, and Mortality: A Systematic Review and Meta-Analysis , 2021, Frontiers in Nutrition.
[63] M. Cutolo,et al. Vitamin D and Lung Outcomes in Elderly COVID-19 Patients , 2021, Nutrients.
[64] B. Gualano,et al. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial. , 2021, JAMA.
[65] R. Quinton,et al. Perspective: Vitamin D supplementation prevents rickets and acute respiratory infections when given as daily maintenance but not as intermittent bolus: implications for COVID-19. , 2021, Clinical medicine.
[66] N. Rezaei,et al. Role of Toll‐like receptors in the pathogenesis of COVID‐19 , 2021, Journal of medical virology.
[67] A. Sette,et al. Adaptive immunity to SARS-CoV-2 and COVID-19 , 2021, Cell.
[68] G. Parati,et al. Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy , 2020, BMC Infectious Diseases.
[69] M. Cutolo,et al. Evidences for a protective role of vitamin D in COVID-19 , 2020, RMD open.
[70] B. García-Pérez,et al. Taming the Autophagy as a Strategy for Treating COVID-19 , 2020, Cells.
[71] J. Mestecky,et al. Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection , 2020, Frontiers in Immunology.
[72] N. Sachdeva,et al. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study) , 2020, Postgraduate Medical Journal.
[73] M. Cazzola,et al. ACE2: The Major Cell Entry Receptor for SARS-CoV-2 , 2020, Lung.
[74] J. Grün,et al. 9‐cis Retinoic acid and 1.25‐dihydroxyvitamin D3 drive differentiation into IgA+ secreting plasmablasts in human naïve B cells , 2020, European journal of immunology.
[75] A. Sette,et al. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19 , 2020, Cell.
[76] R. Goswami,et al. Calcitriol attenuates TLR2/IL-33 signaling pathway to repress Th9 cell differentiation and potentially limits the pathophysiology of rheumatoid arthritis , 2020, Molecular and cellular biochemistry.
[77] C. Camargo,et al. Vitamin D to prevent COVID‐19: recommendations for the design of clinical trials , 2020, The FEBS journal.
[78] R. Bouillon,et al. “Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study” , 2020, The Journal of Steroid Biochemistry and Molecular Biology.
[79] Peihui Wang,et al. SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING Signaling Pathways , 2020, bioRxiv.
[80] David A. Jolliffe,et al. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of aggregate data from randomised controlled trials , 2020, medRxiv.
[81] Sharon J Peacock,et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.
[82] Cuie Chen,et al. Low-Dose Vitamin D Protects Hyperoxia-Induced Bronchopulmonary Dysplasia by Inhibiting Neutrophil Extracellular Traps , 2020, Frontiers in Pediatrics.
[83] A. Malki,et al. Vitamin D Signaling in Inflammation and Cancer: Molecular Mechanisms and Therapeutic Implications , 2020, Molecules.
[84] Shaoying Huang,et al. The cytokine storm and COVID‐19 , 2020, Journal of medical virology.
[85] John H. White,et al. Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions , 2018, Endocrine reviews.
[86] N. Alenina,et al. The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7) , 2017, Physiological reviews.
[87] J. Fleet. The role of vitamin D in the endocrinology controlling calcium homeostasis , 2017, Molecular and Cellular Endocrinology.
[88] David A. Jolliffe,et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data , 2017, British Medical Journal.
[89] S. Johnston,et al. Vitamin D modulation of innate immune responses to respiratory viral infections , 2017, Reviews in medical virology.
[90] M. Cutolo,et al. Steroids and Autoimmunity. , 2017, Frontiers of hormone research.
[91] M. Speeckaert,et al. Behind the scenes of vitamin D binding protein: more than vitamin D binding. , 2015, Best practice & research. Clinical endocrinology & metabolism.
[92] K. Samitas,et al. Vitamin-D in the Immune System: Genomic and Non-Genomic Actions. , 2015, Mini reviews in medicinal chemistry.
[93] A. Martineau,et al. Modulation of the Immune Response to Respiratory Viruses by Vitamin D , 2015, Nutrients.
[94] M. Cutolo,et al. Vitamin D, steroid hormones, and autoimmunity , 2014, Annals of the New York Academy of Sciences.
[95] M. Cutolo,et al. 1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. , 2012, Clinical and experimental rheumatology.
[96] Glenville Jones,et al. 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. , 2012, Archives of biochemistry and biophysics.
[97] M. Haussler,et al. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms. , 2011, Best practice & research. Clinical endocrinology & metabolism.
[98] D. Shin,et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. , 2009, Cell host & microbe.
[99] M. Holick,et al. Vitamin D and Skin Physiology: A D‐Lightful Story , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[100] P. Lips. Vitamin D physiology. , 2006, Progress in biophysics and molecular biology.
[101] M. Hornef,et al. Intracellular Recognition of Lipopolysaccharide by Toll-like Receptor 4 in Intestinal Epithelial Cells , 2003, The Journal of experimental medicine.